The subcommittee heard testimony on breast cancer research and the drug tamoxifen. Studies have shown that a daily dose of tamoxifen reduced the incidence of breast cancer by 45 percent. Researchers and others discussed the drug and its side effects, emphasizing that the drug should be used as a preventative only for certain at-risk women.